Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

Autor:	Michael Hoosien, Ankit Rathod, Ghanshyambhai T. Savani, Juan F. Viles-Gonzalez, Ankit Chothani, Shilpkumar Arora, Vikas Singh, Peeyush Grover, James Lafferty, Vipulkumar Bhalara, Dhaval Khalpada, Neeraj Shah, Kathan Mehta, Thomas Vazzana, Nileshkumar J. Patel, Abhishek Deshmukh, Raul D. Mitrani, Apurva Badheka, Nilay Patel
Rok vydání:	2013
Předmět:	Male medicine.medical_specialty Digoxin Systolic function Severity of Illness Index Ventricular Dysfunction Left Internal medicine Severity of illness Atrial Fibrillation Medicine Humans Aged Retrospective Studies business.industry Follow up studies Atrial fibrillation Retrospective cohort study Middle Aged medicine.disease Cardiology Female Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents All cause mortality medicine.drug Follow-Up Studies
Zdroj:	International journal of cardiology. 169(5)
ISSN:	1874-1754
Popis:	Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function☆☆☆ Nileshkumar J. Patel , Michael Hoosien , Abhishek Deshmukh , Apurva O. Badheka , PeeyushM. Grover , Neeraj Shah , Vikas Singh , KathanMehta , Ankit Chothani , Ghanshyambhai T. Savani , Shilpkumar Arora , Vipulkumar Bhalara , Nilay Patel , Dhaval Khalpada , Ankit Rathod , Thomas J. Vazzana , James Lafferty , Juan F. Viles-Gonzalez , Raul D. Mitrani b,⁎
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa325df31d458d36f6029c6a22c0269 https://pubmed.ncbi.nlm.nih.gov/24377111 Zobrazit plný text záznamu Full Text from ScienceDirect